Caremark RX, L.L.C.
Mount Prospect, IL Part of CVS Health Corporation
- UEI
- EP32BZ8XN3A2
- CAGE
- 5UZ23
- Primary NAICS
- 456110 Pharmacies and Drug Retailers
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, CVS Health Corporation, ranks:
Its parent company, CVS Healthspire Payor & Life Sciences LLC, ranks #4 in PSC B537
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Woonsocket, RI
ZK27LU473Y27
-
Parent
Woonsocket, RI
ZK27LU473Y27
- SAM.gov registration date
- Physical address
- 800 Biermann Ct, Mt Prospect, IL 60056, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $52,997 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Tyvaso | Veterans Integrated Service Network 21 (VHA) | $14,221 | |
| Emergency tyvaso | Veterans Integrated Service Network 21 (VHA) | $0 | |
| Emergency tyvaso | Veterans Integrated Service Network 21 (VHA) | $13,557 | |
| Tyvaso | Veterans Integrated Service Network 21 (VHA) | $13,557 | |
| Tyvaso | Veterans Integrated Service Network 21 (VHA) | $13,557 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Accredo Health Group, Inc. | Memphis, TN | 456110 Pharmacies and Drug Retailers |
| United Therapeutics Corp | Silver Spring, MD | 325412 Pharmaceutical Preparation Manufacturing |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| Curascript SD Specialty Distribution | Lake Mary, FL | 456110 Pharmacies and Drug Retailers |
| Actelion Pharmaceuticals US, Inc. | Hopewell Township, NJ | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Caremark RX, L.L.C., doing business as Prescription Service, is a for-profit limited liability company that provides pharmaceuticals and related services. As shown by its recent federal contract award history, Caremark supplies specialty pharmaceuticals to Veterans Affairs medical centers through purchase orders.
Specifically, Caremark has provided treprostinil-based medications indicated for pulmonary arterial hypertension, including Tyvaso and Remodulin, to VA Integrated Service Networks across the country. Additional drugs supplied include Northera for neurogenic orthostatic hypotension. The contract awards have generally been short-term purchase orders placed on an as-needed basis without set-aside designations, with completion dates within several months and values ranging from about $10,000 to $85,000. Caremark has provided these niche medications directly to VA as a prime contractor.
Quick answers
Is Caremark RX, L.L.C. registered in SAM.gov?
Yes. Caremark RX, L.L.C.'s SAM.gov registration is active through October 15, 2027.
What is Caremark RX, L.L.C.'s CAGE code?
Caremark RX, L.L.C.'s CAGE code is 5UZ23, and its Unique Entity ID (UEI) is EP32BZ8XN3A2.
How much has Caremark RX, L.L.C. received in federal contracts?
Federal contracts obligated $52,997 to Caremark RX, L.L.C. in fiscal years 2023 through 2027.
How does Caremark RX, L.L.C. rank among federal contractors?
Caremark RX, L.L.C.'s parent company, CVS Health Corporation, ranked #1 in NAICS 456, #12 in PSC Q517 and #23 in NAICS 44-45 in FY2025.
What is Caremark RX, L.L.C.'s most recent federal award?
Caremark RX, L.L.C.'s most recent federal contract award is Tyvaso (36C26123P0628), from Veterans Integrated Service Network 21 (VHA), on February 2, 2023.
On GovTribe
See Caremark RX, L.L.C.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors